
|Videos|April 26, 2018
Small-Molecule TKIs: Potential Benefit in Multiple Malignancies
Author(s)Brian Schwartz, MD
In this video, Dr. Brian Schwartz highlights several small-molecule TKIs in development with the potential to help patients with several malignancies.
Advertisement
In this video, Dr. Brian Schwartz highlights several small-molecule TKIs in development with the potential to help patients with several malignancies.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel Cancer Vaccine Receives FDA Orphan Drug Designation in Cutaneous Melanoma
2
FDA Accepts NDA for Zanzalintinib/Atezolizumab in Pretreated Metastatic CRC
3
How Would the Teclistamab Combo Approval Transform Multiple Myeloma?
4
FDA Accepts NDA for Rivoceranib and Camrelizumab in 1L Unresectable HCC
5
































